All Supplements
    Supplement

    Pasteurized Akkermansia Muciniphila

    Supplement
    Gut Health
    6/10 Evidence

    A next-generation probiotic derived from a keystone mucin-degrading gut bacterium associated with metabolic health, supplied as a heat-pasteurized (non-living) preparation shown in multiple RCTs to improve metabolic markers.

    Mechanism of Action

    A. muciniphila reinforces gut barrier/mucus-layer integrity; pasteurization increases abundance of the outer-membrane protein Amuc_1100, which activates TLR2 signaling and appears to enhance, not diminish, its metabolic effects versus the live form.

    Dosing Protocol

    Recommended

    10billion pasteurized cells/day

    Standard starting dose based on research

    Therapeutic Range

    3

    Minimum

    to

    10

    Maximum

    billion pasteurized cells/day

    Once daily; trials have used both with and without food — take consistently at the same time each day

    Cycling Protocol

    No cycling established; trials dosed continuously for up to 3 months

    Dosages are general guidelines. Individual requirements vary based on body weight, health status, and specific goals. Start with lower doses and adjust based on response.

    Benefits

    Primary Benefits

    • In a 90-adult RCT in overweight/obesity (Nature Medicine, 2026), pasteurized A. muciniphila MucT reduced weight regain during a maintenance phase versus placebo (1.2±0.7kg vs 3.2±0.4kg) and improved net weight loss from baseline
    • In a 142-adult multicenter RCT in metabolic syndrome (2026), participants with low baseline Akkermansia levels showed improved insulin sensitivity and GLP-1 response after 3 months versus placebo
    • An earlier proof-of-concept RCT (Depommier et al., Nature Medicine 2019, n=32) found pasteurized Akkermansia improved insulin sensitivity and reduced insulinemia, total cholesterol, and modestly body weight/fat mass over 3 months

    Secondary Benefits

    Associated observationally with lower gut permeability and inflammatory markers
    Under investigation as an adjunct to weight-loss maintenance after GLP-1 agonist discontinuation

    Safety Information

    Contraindications

    Do not use if any of the following apply:

    • •Severe immunocompromise (no safety data in immunocompromised populations)
    • •Not studied in pregnancy or breastfeeding

    Drug/Supplement Interactions

    May interact with the following. Consult a healthcare provider before combining:

    No known drug interactions identified in trials to date
    Theoretical additive effect with other gut-barrier-targeted probiotics/prebiotics — unstudied combination

    Potential Side Effects

    Some users may experience:

    Well tolerated in all published RCTs to date with no treatment-related serious adverse events
    Mild, transient GI symptoms reported infrequently

    This is not a complete list of interactions or side effects. Individual responses vary. Always start with the lowest effective dose and monitor your response. Report any adverse effects to your healthcare provider.

    Quality Markers

    Look for these specific quality indicators when sourcing this compound:

    • Confirm the product uses the pasteurized (heat-killed) MucT strain used in clinical trials — distinct from unstudied 'live' Akkermansia products
    • Manufacturer cold-chain/stability data, since pasteurized bacterial products remain storage-sensitive
    • Third-party strain identity verification

    Trusted Certifications

    NSF Certified
    USP Verified
    GMP Certified
    ConsumerLab Approved

    Note: Supplement quality varies dramatically between brands. Cheap supplements often contain fillers, incorrect doses, or contaminants. Investing in quality products from reputable manufacturers is essential for safety and efficacy.

    Evidence Profile

    Evidence Score

    6/10

    Moderate Evidence

    Some clinical trials with positive results, emerging research

    Classification:
    Moderate — multiple peer-reviewed, placebo-controlled human RCTs (2019–2026) consistently show benefits on insulin sensitivity and weight-loss maintenance; effect sizes are modest and most trials are funded by the sole commercial producer, so independent replication and longer-term outcome data remain limited Evidence

    Evidence Scale

    8-10

    Strong

    5-7

    Moderate

    1-4

    Emerging

    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation